Tenax Therapeutics Announces Review of Strategic Alternatives and Business Update
Go back to Tenax Therapeutics Announces Review of Strategic Alternatives and Business Update| LADENBURG THALMANN FNCL. (NYSE: LTS) | Delayed: 3.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.49 | 52 Week High | $3.28 | |||
| Open | $3.82 | 52 Week Low | $1.63 | |||
| Day High | $3.49 | P/E | N/A | |||
| Day Low | $3.49 | EPS | $-0.03 | |||
| Volume | 8,178 | |||||
| (NASDAQ: TENX) | Delayed: 1.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.84 | 52 Week High | $3.40 | |||
| Open | $1.84 | 52 Week Low | $1.34 | |||
| Day High | $1.84 | P/E | N/A | |||
| Day Low | $1.84 | EPS | $0.00 | |||
| Volume | 41,923 | |||||
